Indo-Bangla Pharmaceuticals Limited

Nature of business The Company is engaged in manufacturing and selling of all kinds of medicine (excluding Antibiotic), medical preparations drugs & chemicals (Human Health). The Company applied for permission for production and selling of veterinary medicine also
Reason for IPO Construction and other civil works 58,580,000 (29.29%) Machineries 124,720,000(62.36%) IPO expenses 16,700,000 (08.35%) Total 200,000,000 (100.00%)
Subscription open 08 Apr 2018
Subscription close 18 Apr 2018
Subscription close for NRB 08 Apr 2018 to 18 Apr 2018
Offer price Tk. 10.0
Face value per share Tk. 10.0
Market lot 500 units
Single lot price Tk. 5000.0
EPS Tk. 1.21 for the period ended on June 30, 2017
NAV Tk. 12.84 as at June 30, 2017
Public offer
Major product Indo-Bangla Pharmaceuticals Ltd. produces a good number of products of Human products division. All the products of IndoBangla Pharmaceuticals Ltd. categorized under Non Biological Products and Biological Products.
Issue Manager 1. AFC Capital Limited 2. EBL Investments Limited 3. CAPM Advisory Limited
Website http://www.indo-banglapharma.com

BDIPO_ad_id